ArticleJournal of oncology2020

Pathological Mechanistic Studies of Osimertinib Resistance in Non-Small-Cell Lung Cancer Cells Using an Integrative Metabolomics-Proteomics Analysis.

Qing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.